These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 901737)

  • 21. Effect of bromocriptine on maturity onset diabetes.
    Barnett AH; Chapman C; Gailer K; Hayter CJ
    Postgrad Med J; 1980 Jan; 56(651):11-4. PubMed ID: 6992131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of long-term tolbutamide treatment on glucose tolerance and insulin secretion in maturity-onset diabetes without obesity.
    Lauvaux JP; Mandart G; Heymans G; Ooms HA
    Horm Metab Res; 1972 Mar; 4(2):58-62. PubMed ID: 5028221
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of long term sulfonylurea therapy on plasma insulin and fasting lipid levels.
    Podolsky S; Burney SW
    Diabete Metab; 1979 Jun; 5(2):113-7. PubMed ID: 478080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of glibenclamide treatment on the insulin and glucagon responses to oral glucose and galactose in maturity onset diabetics.
    Hayes JR; Callaghan S; Grant AP
    Diabete Metab; 1979 Sep; 5(3):207-11. PubMed ID: 115730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of treatment with diet alone on oral glucose-tolerance test and plasma sugar and insulin levels in patients with maturity-onset diabetes mellitus.
    Doar JW; Wilde CE; Thompson ME; Sewell PF
    Lancet; 1975 Jun; 1(7919):1263-6. PubMed ID: 48896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immuno reactive insulin responses to glycemic stimulus in maturity onset diabetics effect of severity and body weight.
    Viswanathan M; Snehalatha C; Ramachandran A; Viswanathan M
    J Assoc Physicians India; 1978 Aug; 26(8):687-93. PubMed ID: 754707
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of clofibrate on glucide tolerance in patients with ischemic heart disease and hyperlipoproteinemia].
    Bornemisza P; Csögör I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978; 30(6):543-6. PubMed ID: 34860
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasma insulin and glucose levels in maturity onset diabetics treated with chlorpropamide.
    Shenfield GM; Logan A; Shirling D; Baird J
    Diabetologia; 1977 Aug; 13(4):367-71. PubMed ID: 913926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma trivalent chromium, glucose tolerance and insulin secretion in juvenile- and adult-onset diabetes mellitus.
    Gedik O; Unal S; Koray Z
    Isr J Med Sci; 1980 Aug; 16(8):563-5. PubMed ID: 6998922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of clofibrate on plasma glucose, lipoproteins, fibrinogen, and other biochemical and haematological variables in patients with mature onset diabetes mellitus.
    Calvert GD; Blight L; Franklin J; Oliver J; Wise P; Gallus AS
    Eur J Clin Pharmacol; 1980 May; 17(5):355-62. PubMed ID: 6998709
    [No Abstract]   [Full Text] [Related]  

  • 31. Maturity onset diabetes mellitus: response to intensive dietary management.
    Hadden DR; Montgomery DA; Skelly RJ; Trimble ER; Weaver JA; Wilson EA; Buchanan KD
    Br Med J; 1975 Aug; 3(5978):276-8. PubMed ID: 1148773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of clofibrate administration on plasma post-heparin lipolytic activity in man.
    Maruhama Y; Yanbe A; Abe R; Oneda A; Yamagata S
    Tohoku J Exp Med; 1974 Aug; 113(4):343-9. PubMed ID: 4446025
    [No Abstract]   [Full Text] [Related]  

  • 33. [Disorders of glucose metabolism and manifestation of diabetes during treatment of endogenous hypertriglyceridemias (author's transl)].
    Vogelberg KH; Dannehl K; Gries FA
    MMW Munch Med Wochenschr; 1981 Nov; 123(48):1862-6. PubMed ID: 6796867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intensified therapy of newly detected maturity onset diabetes].
    Pissarek D; Panzram G; Lundershausen R; Adolph W; Senf L
    Endokrinologie; 1980 Jan; 75(1):105-15. PubMed ID: 6989592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The basal plasma glucose: a simple relevant index of maturity-onset diabetes.
    Holman RR; Turner RC
    Clin Endocrinol (Oxf); 1981 Mar; 14(3):279-86. PubMed ID: 7021010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement in glucose tolerance due to Momordica charantia (karela).
    Leatherdale BA; Panesar RK; Singh G; Atkins TW; Bailey CJ; Bignell AH
    Br Med J (Clin Res Ed); 1981 Jun; 282(6279):1823-4. PubMed ID: 6786635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of control of blood glucose on plasma insulin responses to various stimuli in secondary failures to oral hypoglycemic agents and in newly diagnosed, maturity onset, ketosis-resistant diabetics.
    Schmeltz R; Wendorff HJ; Field JB
    J Clin Endocrinol Metab; 1978 Apr; 46(4):519-27. PubMed ID: 755038
    [No Abstract]   [Full Text] [Related]  

  • 38. [Influence of clofibrate on carbohydrate metabolism in diabetics].
    Carapezzi C; Palummeri E; Soncini G; Bastoni L; Passeri M
    G Clin Med; 1976; 57(3-4):113-25. PubMed ID: 1001854
    [No Abstract]   [Full Text] [Related]  

  • 39. Diurnal variation in oral glucose tolerance: blood sugar and plasma insulin levels morning, afternoon, and evening.
    Jarrett RJ; Baker IA; Keen H; Oakley NW
    Br Med J; 1972 Jan; 1(5794):199-201. PubMed ID: 5058728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes.
    DeFronzo R; Deibert D; Hendler R; Felig P; Soman V
    J Clin Invest; 1979 May; 63(5):939-46. PubMed ID: 376552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.